股本结构
单位：万股
| 公告日期 | 2018-03-08 | 2017-10-27 | 2017-10-27 | 2017-08-03 | 2017-08-03 | 2017-05-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 10822.36 | 10819.99 | 10818.40 | 10818.20 | 10816.45 | 10815.99 |
| 普通股本 | 10822.36 | 10819.99 | 10818.40 | 10818.20 | 10816.45 | 10815.99 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2018-02-09 | 2017-10-25 | 2017-09-30 | 2017-08-01 | 2017-06-30 | 2017-05-01 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2018-03-08 | 10822.36 | 未披露 | 定期报告 | 2018-02-09 |
| 2017-10-27 | 10819.99 | 未披露 | 定期报告 | 2017-10-25 |
| 2017-10-27 | 10818.40 | 未披露 |
更多>>
From December 31, 2016 to September 30, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
|
2017-09-30 |
| 2017-08-03 | 10818.20 | 未披露 | 定期报告 | 2017-08-01 |
| 2017-08-03 | 10816.45 | 未披露 |
更多>>
from December 31, 2016 to June 30, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
|
2017-06-30 |
| 2017-05-12 | 10815.99 | 未披露 | 定期报告 | 2017-05-01 |
| 2017-05-12 | 10813.29 | 未披露 |
更多>>
from December 31, 2016 to March 31, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
|
2017-03-31 |
| 2017-02-02 | 10795.20 | 未披露 |
更多>>
1.one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), for every two shares of Biogen common stock held by Biogen stockholders as of the close of business on January 17, 2017
|
2017-02-02 |
| 2017-01-11 | 21590.40 | 未披露 | 定期报告 | 2016-12-01 |
From December 31, 2016 to September 30, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
from December 31, 2016 to June 30, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
from December 31, 2016 to March 31, 2017
Issuance of common stock upon separation
Shares issued under employee benefit plans
1.one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), for every two shares of Biogen common stock held by Biogen stockholders as of the close of business on January 17, 2017